博文

Is Immunotherapy Feasible in Chronic Acute Liver Failure?

日期：
0

NAFLD Related Liver Cancer Risk Screening and Intervention

日期：
0

Risk Stratification and Treatment Options of Medium-Term HCC

日期：
0

Targeting cccDNA - the Clinical Cure of Chronic Hepatitis B

日期：
0

Prediction and Treatments Selection of Immunotherapy for Patients with HCC

日期：
0

How should pregnant women with chronic HBV or HCV infection receive antiviral treatment?

日期：
0

Prognostic Value of Non-Invasive Detection in Patients with NAFLD

日期：
0

The first targeted drug of cholangiocarcinoma, peimitinib, has both efficacy and safety -- The final results of FIGHT-202

日期：
0

Liver cancer screening in patients with liver cirrhosis can improve the early diagnosis, early treatment and survival rate

日期：
0

The efficacy and safety of double immunity combined STRIDE regimen in unresectable hepatocellular carcinoma

日期：
0